Human herpesvirus 8-negative malignant effusion lymphoma: A distinct clinical entity and successful treatment with rituximab

Leukemia and Lymphoma

Volumn 46, Issue 3, 2005, Pages 415-419

  Matsumoto, Yosuke ^a   Nomura, Kenichi ^a   Ueda, Kyoji ^a   Satoh, Kazumi ^b   Yasuda, Norimasa ^c   Taki, Tomohiko ^d   Yokota, Shohei ^a   Horiike, Shigeo ^a   Okanoue, Takeshi ^a   Taniwaki, Masafumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b National Hospital Organization Minami Kyoto Hospital   (Japan)

^c KYOTO CITY HOSPITAL   (Japan)

^d Laboratory Medicine   (Japan)

Author keywords

Effusion lymphoma; Human herpesvirus 8; Rituximab

Indexed keywords

CD19 ANTIGEN; CD20 ANTIBODY; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; PIRARUBICIN; RITUXIMAB; VINCRISTINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER CLASSIFICATION; CASE REPORT; CLINICAL FEATURE; CYTOLOGY; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOPHENOTYPING; KAPOSI SARCOMA; LYMPHOID CELL; LYMPHOMA; MALAISE; MALE; PLEURA EFFUSION; PLEURA EMPYEMA; PLEURA FLUID; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, B-CELL; MALE; PLEURAL EFFUSION, MALIGNANT;

EID: 20844463218     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400018364     Document Type: Article

References (17)

1. Jaffe ES, Harris NL, Stein H, Vardiman JW. editors. World Health Organization Classification of Tumors. Pathology and Genetics, Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. pp 179-180.
2. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996;88:645-656.
3. Iuchi K, Ichimiya A, Akashi A, Mizuta T, Lee YE, Tada H, Mori T, Sawamura K, Lee YS, Furuse K, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 1987;60:1771-1775.
4. Nakatsuka S, Yao M, Hoshida Y, Yamamoto S, Iuchi K, Aozasa K. Pyothorax-associated lymphoma: a review of 106 cases. J Clin Oncol 2002;20:4255-4260.
5. Hermine O, Michel M, Buzyn-Veil A, Gessain A. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. N Engl J Med 1996;334:272-273.
6. Carbone A, Gloghini A, Vaccher E, Zagonel V, Pastore C, Dalla Palma P, Branz F, Saglio G, Volpe R, Tirelli U, Gaidano G. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 1996;94:533-543.
7. Ascoli V, Lo Coco F, Artini M, Levrero M, Fruscalzo A, Mecucci C. Primary effusion Burkitt's lymphoma with t(8;22) in a patient with hepatitis C virus-related cirrhosis. Hum Pathol 1997;28:101-104.
8. Carbone A, Cilia AM, Gloghini A, Canzonieri V, Pastore C, Todesco M, Cozzi M, Perin T, Volpe R, Pinto A, Gaidano G. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions. Int J Cancer 1997;73:562-569.
9. Ichinohasama R, Miura I, Kobayashi N, Saitoh Y, DeCoteau JF, Saiki Y, Mori S, Kadin ME, Ooya K. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 1998;22:1528-1537.
10. Ashihara E, Shimazaki C, Hirai H, Inaba T, Hasegawa G, Mori S, Nakagawa M. Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube. Int J Hematol 2001;74:327-332.
11. Tanaka S, Katano H, Tsukamoto K, Jin M, Oikawa S, Nishihara H, Sawa H, Sawada K, Shimizu M, Sata T, et al. HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 2001;51:293-300.
12. Rodriguez J, Romaguera JE, Katz RL, Said J, Cabanillas F. Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus. Leuk Lymphoma 2001;41:185-189.
13. Hara T, Nishi S, Horimoto A, Takenaka S, Ibata Y, Akamatsu H. Primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. J Gastroenterol Hepatol 2001;16:948-949.
14. Yamamoto Y, Kitajima H, Sakihana H, Shigeki T, Fukuhara S. CD3 + CD4-CD8-TCR-alphabeta+ T-cell lymphoma with clinical features of primary effusion lymphoma: an autopsy case. Int J Hematol 2001;74:442-446.
15. Ohshima K, Ishiguro M, Yamasaki S, Miyagi J, Okamura S, Sugio Y, Muta T, Sasaki H, Tuchiya T, Kawasaki C, Kikuchi M. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Leuk Lymphoma 2002;43:595-601.
16. Shimazaki M, Fujita M, Tsukamoto K, Matsuki T, Iwata M, Takahashi H, Doi A, Hyakkoku M, Yamauchi K, Genda S, et al. An unusual case of primary effusion lymphoma in a HIV-negative patient not pathogenetically associated with HHV8. Eur J Haematol 2003;71:62-67.
17. Perez CL, Rudoy S. Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient. Clin Diagn Lab Immunol 2001;8:993-996.